BamSEC and AlphaSense Join Forces
Learn More

Rockwell Medical Inc.

NASDAQ: RMTI    
Share price (12/23/24): $2.11    
Market cap (12/23/24): $68.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 28 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment No. 1 to Asset Purchase Agreement
12/34/56
EX-10.32
from 10-K 6 pages Rockwell Medical, Inc. Amended and Restated Statement of Company Policy Prohibiting Insider Trading
12/34/56
EX-10.31
from 10-K 3 pages Rockwell Medical, Inc. Amended and Restated Clawback Policy
12/34/56
EX-10.30
from 10-K 28 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 23 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.3
from 10-Q 13 pages Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan I. General Provisions
12/34/56
EX-10.2
from 10-Q 35 pages Asset Purchase Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Holder of Common Stock Purchase Warrant Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.33
from 10-K 3 pages Restricted Stock Unit Award Agreement
12/34/56
EX-10.32
from 10-K 3 pages Restricted Stock Unit Award Agreement
12/34/56
EX-10.15
from 10-K 16 pages Distribution Termination and Acquisition Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Stock Option Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Rockwell Medical, Inc. Short-Term Incentive Plan (Annual Bonus Plan) Section 1: Establishment of Plan; Purpose of Plan
12/34/56
EX-10.8
from 10-Q 20 pages Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan I. General Provisions
12/34/56
EX-10.7
from 10-Q 26 pages Employment Agreement This Employment Agreement (The “Agreement”) Is Made as of June 21, 2022 (The “Effective Date”), by and Between Rockwell Medical, Inc., a Delaware Corporation (The “Company”), and Mark Strobeck, PH.D. (“Executive”), Subject to the Terms and Conditions Defined in This Agreement
12/34/56
EX-10.3
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 10 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Amendment One to Products Purchase Agreement
12/34/56